Gestational Diabetes and Risk Assessment of Adverse Perinatal Outcomes and Newborns Early Motoric Development

Milan Lackovic1,2, Biljana Milicic3, Sladjana Mihajlovic1,2

  • 1Clinical Hospital Center "Dr. Dragiša Mišović", 11000 Belgrade, Serbia.

Insights

Gestational diabetes mellitus (GDM) is linked to numerous adverse perinatal outcomes and impacts infant motor development. Early identification and glycemic control are crucial for at-risk pregnancies.

Area of Science:

  • Obstetrics and Gynecology
  • Neonatal Development
  • Endocrinology

Background:

  • Gestational diabetes mellitus (GDM) affects maternal and fetal health.
  • Its impact on neonatal motor development requires further investigation.

Purpose of the Study:

  • To analyze the association between GDM and maternal/fetal perinatal parameters.
  • To evaluate GDM's influence on early neonatal motoric development.

Main Methods:

  • Prospective study of 203 obstetrics patients.
  • Assessment of GDM using maternal and fetal parameters.
  • Evaluation of infant motor development via the Alberta Infant Motor Scale (AIMS).

Main Results:

  • GDM associated with increased maternal weight, BMI, and glucose levels.
  • GDM linked to large for gestational age (LGA) infants and specific delivery modes.
  • GDM showed associations with various fetal ultrasound parameters and infant motor milestones at 3 and 6 months.

Conclusions:

  • Numerous perinatal parameters and early motor development are significantly associated with GDM.
  • Highlights the need for clinical strategies for at-risk pregnancies.
  • Emphasizes the importance of glycemic control and regular prenatal follow-ups.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.1K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.9K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.1K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
353